Source comparison
CJC-1295 Not Working Reasons Fix: Comparison Table
Storage above 8°C Thermal denaturation of tertiary structure. Peptide unfolds, loses receptor binding affinity None (solution remains clear) Store on middle/lower fridge shelf at 2–8°C; never in door; use within 28 days of reconstitution Immediate (next dose a
This comparison does not assign a generated winner or score.
- Storage above 8°C
- Thermal denaturation of tertiary structure. Peptide unfolds, loses receptor binding affinity
- None (solution remains clear)
- Store on middle/lower fridge shelf at 2–8°C; never in door; use within 28 days of reconstitution
- Immediate (next dose at full potency if new vial used)
- Reconstitution technique error
- Shear forces or direct injection onto powder breaks disulfide bonds
- None (solution appears normal)
- Add bacteriostatic water slowly down vial wall; swirl gently, never shake
- Immediate (applies to next vial only. Current vial cannot be recovered)
- Inconsistent injection timing
- Plasma levels drop below therapeutic threshold between doses
- Symptom recurrence 4–5 days post-injection
- Inject every 7 days ±12 hours for DAC; every 3–4 days for non-DAC
- 2–3 injection cycles to re-establish steady state
- Light exposure during storage
- Oxidation of methionine residues reduces bioactivity
- Wrap vial in foil or use amber glass vials; store in dark section of fridge
- Immediate (next dose from protected vial)
- Injection site variability
- Absorption rate differences create peak-to-trough fluctuations
- Results inconsistent week-to-week
- Use abdominal subcutaneous injections exclusively; rotate within 2-inch radius only
- 2–3 weeks to stabilize pharmacokinetics